HR 10798 Introduced Re-checks Congress.gov for new actions and updates the bill's status, and fills in any sponsors, committees, or related bills that are missing. It does not re-pull sponsors/cosponsors/committees/related — those rarely change — and it skips all work if nothing has changed upstream, so it's cheap to click.
Silicosis Prevention and Treatment Act
To establish a grant program for funding silicosis treatment and education, and for other purposes.
Summary
- Directs the Secretary of Health and Human Services, through HRSA, to award competitive grants to treat silicosis regardless of ability to pay and to educate workers in high-exposure industries.
- Limits eligible grantees to federally qualified health centers, hospitals, state or local health departments, and nonprofit health care clinics or providers.
- Allows grant funds to pay for silicosis outreach, screening, diagnosis, and treatment, patient and worker education, benefits counseling, patient care coordination, and pulmonary rehabilitation, along with other activities the Secretary approves.
- Authorizes $10,000,000 for each of fiscal years 2027 through 2031 to carry out the program.
AI-generated plain-language summary of the bill text — neutral, and may be imperfect. See the full text below for the exact wording.
Sponsor (1)
-
Rep. Correa, J. Luis (D-CA) [#46]
2 cosponsors
-
Rep. Costa, Jim (D-CA) [#21] -
Rep. Dexter, Maxine (D-OR) [#3]
Actions (2)
- Oct 13, 2026 Referred to the House Committee on Energy and Commerce. · house
- Oct 13, 2026 Introduced in House
Full text
IN THE HOUSE OF REPRESENTATIVES
October 13, 2026
Mr. Correa (for himself and Ms. Dexter) introduced the following bill; which was referred to the Committee on Energy and Commerce
A BILL
To establish a grant program for funding silicosis treatment and education, and for other purposes.
Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the “Silicosis Prevention and Treatment Act”.
SEC. 2. SILICOSIS CLINICS PROGRAM.
(a) Establishment.—The Secretary of Health and Human Services, acting through the Administrator of the Health Resources and Services Administration, (in this section referred to as the “Secretary”) shall award grants, on a competitive basis, to eligible entities to treat individuals with silicosis, regardless of their ability to pay, and provide education to workers in industries with high exposure to silica.
(b) Eligible Entities.—To be eligible for a grant under this section, an entity shall be—
(1) a federally qualified health center (as defined in section 1861(aa) of the Social Security Act (42 U.S.C. 1395x(aa)));
(2) a hospital;
(3) a State or local health department; or
(4) a nonprofit health care clinic or nonprofit health care provider.
(c) Use of Funds.—A grant awarded under this section may be used for—
(1) outreach and education to raise awareness of silicosis;
(2) screening, diagnosis, and treatment of silicosis;
(3) education programs for patients, family members, and workers in industries heavily impacted by silicosis;
(4) benefits counseling related to silicosis (including with respect to State and Federal compensation programs);
(5) patient care and coordination related to silicosis (including individual patient care plans and referrals, as needed);
(6) pulmonary rehabilitation to improve breathing in relation to silicosis; or
(7) such other activities as the Secretary determines appropriate.
(d) State Defined.—In this section, the term “State” means each of the several States, the District of Columbia, a territory or possession of the United States, or an Indian Tribe.
(e) Authorization of Appropriations.—There is authorized to be appropriated to carry out this section $10,000,000 for each of fiscal years 2027 through 2031. <all>
Comments